Spero Therapeutics vs Tango Therapeutics
SPRO and TNGX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SPRO and TNGX compare
Tango Therapeutics is the larger company, worth 72 times as much as Spero Therapeutics ($4.2B against $58.2M).
Spero Therapeutics grew revenue faster over the last twelve months (2.5% versus −100% for Tango Therapeutics).
Tango Therapeutics scores higher on the StockData Score (8 against 6 for Spero Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SPRO | TNGX |
|---|---|---|
| Size and price | ||
| Market cap | $58.2M | $4.2B |
| Share price | $1.00 | $24.85 |
| Change, 1 year | −61.8% | 197% |
| Change, 5 years | −93.9% | 108% |
| Beta (5Y) | 1.12 | 1.18 |
| Employees | 25 | 137 |
| StockData Score | ||
| Total score | 6 | 8 (better) |
| Valuation score | 0 | 0 |
| Growth score | 0 | 1 (better) |
| Performance score | 1 | 1 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.4× | – |
| P/B | 74.6× | 4.3× (better) |
| FCF yield | – | −3.6% |
| Growth | ||
| Revenue growth (TTM) | 2.5% (better) | −100% |
| Revenue growth, 5Y average | 48.2% | 52.1% (better) |
| Profitability | ||
| Operating margin | −67.3% | – |
| Net margin | −71.0% | – |
| Return on equity | −216% | −36.5% (better) |
| Return on invested capital | – | −3646% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 1.92 | 39.45 (better) |
| Altman Z-score | −6.09 | 46.53 (better) |
| Piotroski F-score | 5 (better) | 4 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 36.9% | 127% |
| Held by insiders | 24.6% | 11.7% |
| Insider net buying, 12 months | −$499K (better) | −$8.0M |
| Short interest, % of float | 1.8% | 32.4% |
Go deeper
- SPRO stock overview
- SPRO income statement
- SPRO valuation and score
- TNGX stock overview
- TNGX income statement
- TNGX valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.